图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
肿瘤形成评论综述™
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN 打印: 0893-9675
ISSN 在线: 2162-6448

肿瘤形成评论综述™

DOI: 10.1615/CritRevOncog.2017024841
pages 263-273

Tumor-Suppressing Properties of Crocus sativus L.: Nature as an Anti-Cancer Agent

Eleni Kakouri
Laboratory of Chemistry, Department of Food Science and Human Nutrition, School of Food Biotechnology and Development, Agricultural University of Athens, Greece
Kyriaki Hatziagapiou
First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Haematology and Oncology Unit, Athens, Greece
Kostas Bethanis
Biotechnology Department, Physics Lab, Agricultural University of Athens, Greece
Olti Alexandra Nikola
First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Haematology and Oncology Unit, Athens, Greece
George I. Lambrou
First Department of Pediatrics, National and Kapodistrian University of Athens, Choremeio Research Laboratory, Haematology and Oncology Unit, Athens, Greece
Petros A. Tarantilis
Laboratory of Chemistry, Department of Food Science and Human Nutrition, School of Food Biotechnology and Development, Agricultural University of Athens, Greece

ABSTRACT

Cancer is a growing problem because it is a chronic disease that affects, not only patient health, but also its daily living. Concurrent cancer therapies have ameliorated cancer prevalence, but the severity and frequency of toxicity and side effects during therapy have led the scientific community to rediscover the possible therapeutic effectiveness of herbs and spices. Crocus sativus L., commonly known as saffron, has been used in folk medicine for centuries. Today, data from numerous in vivo and in vitro studies support its anti-cancer activity, making it a promising anti-cancer agent for study. In the present review, we focus on the anti-cancer activity of C. sativus and its derivates. Medications that are currently used as chemotherapeutic or anti-cancer agents are associated with side effects whether used at effective doses or at levels that exceed the therapeutic dose. Therefore, many cancer survivors suffer from serious and even life-threatening long- or short-term sequelae, so the development of alternative/coadjutant drugs is imperative.


Articles with similar content:

Polymer-Based Drug Delivery Systems for Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 6
Ru Wen, Ammad Ahmad Farooqi, Afoma C. Umeano, Pingping Chen
The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 10
Martina Cizmarikova
Treatment of Chemotherapy Induced Peripheral Neuropathy: The Role of Medicinal Herbs
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 1
Sven Schroeder, Gesa Meyer-Hamme, Thomas Friedemann
Long-Acting Injectables: Current Perspectives and Future Promise
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 2
Komal Chaudhary, Mayur M. Patel, Priti J. Mehta
An Update on Angiogenesis Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Vinod Labhasetwar, Jasmine Davda